文献速递肾癌与肾肿瘤

散发性双侧多灶性乳头状肾细胞癌的自然史、肿瘤生长动力学及肾功能结局:25年前瞻性队列研究

Natural History, Tumor Growth Kinetics, and Renal Functional Outcomes of Sporadic Bilateral Multifocal Papillary Renal Cell Carcinoma: A 25-yr Prospective Cohort Study.
PubMed 文献 · Eur Urol Oncol · 2026-08-10

基于美国国家癌症研究所1999—2025年前瞻性数据库,89例临床散发性双侧多灶性乳头状肾细胞癌患者中位随访50个月,6例(6.7%)发生转移且均见于最大肿瘤>3 cm者;105个监测肿瘤中64%出现增长,中位生长速率1.55 mm/年;同侧再次部分肾切除与肾功能显著下降相关。

要点

  • 最大肿瘤<3 cm者未观察到转移事件。
  • 监测肿瘤中位生长速率1.55 mm/年,支持主动监测。
  • 同侧再次部分肾切除与eGFR显著下降相关。

核心结论

  • 散发性双侧多灶性乳头状肾细胞癌多呈惰性生长、转移潜能低,最大肿瘤<3 cm者未观察到转移事件。

研究设计与样本

  • 前瞻性机构数据库(美国国家癌症研究所,1999—2025年)纳入89例组织病理确诊的临床散发性双侧多灶性乳头状肾细胞癌患者。
  • 对44例患者共105个肿瘤(系列横断面影像随访≥6个月)评估主动监测。

主要发现

  • 中位随访50个月,6例(6.7%)发生转移,均见于评估时最大肿瘤>3 cm的患者。
  • 共实施156次肾脏手术,以部分肾切除为主(81%)。
  • 649个肿瘤中18个(2.8%;95%CI 1.8%—4.3%)检出变异病理。
  • 105个影像监测肿瘤中64%出现间期增长,中位生长速率1.55 mm/年(IQR 1.24—1.81)。
  • 同侧再次部分肾切除后肾功能显著下降(中位eGFR 80.9→63.5 ml/min/1.73 m²;p=0.002)。

临床怎么用

  • 小肾mass(最大肿瘤<3 cm)可考虑主动监测。
  • 需干预时优先选择保留肾单位手术。
  • 再次同侧部分肾切除需权衡肾功能下降风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: Bilateral or multifocal (BMF) papillary renal cell carcinoma (pRCC) arising without a confirmed pathogenic germline variant represents a clinically distinct entity with a poorly defined natural history. We aimed to establish clinical benchmarks for tumor growth kinetics, oncologic outcomes, and renal functional impact in this entity. PATIENTS AND METHODS: We identified 89 patients with histopathologically confirmed clinically sporadic BMF pRCC from a prospectively maintained, institutional review board-approved database at the National Cancer Institute (1999-2025). Tumor growth rate was calculated with a linear mixed-effects model. Active surveillance was assessed in 105 tumors from 44 patients with ≥6 mo of serial cross-sectional imaging. KEY FINDINGS AND LIMITATIONS: Over a median follow-up of 50 months, metastatic disease developed in six patients (6.7%), exclusively among patients whose largest tumor exceeded 3 cm at the time of assessment. A total of 156 renal procedures were performed, with partial nephrectomy predominating (81%). Variant pathology was identified in 18 of the 649 tumors (2.8%; 95% confidence interval 1.8%-4.3%). Among the 105 radiographically surveilled tumors, 64% demonstrated interval growth. The median tumor growth rate was 1.55 mm/yr (interquartile range 1.24-1.81). Repeat ipsilateral partial nephrectomy was associated with a significant decline in renal function (median estimated glomerular filtration rate 80.9-63.5 ml/min/1.73 m2; p = 0.002). CONCLUSIONS AND CLINICAL IMPLICATIONS: Sporadic BMF pRCC demonstrates predominantly indolent growth and low metastatic potential, with no metastatic events observed in patients presenting with a largest tumor <3 cm. These findings provide growth-rate benchmarks consistent with active surveillance for small renal masses and nephron-sparing surgery when intervention is warranted.

来源:Eur Urol Oncol,查看原文。版权归原作者所有。

引用

  1. Fu H, Blachman-Braun R, Loebach L, et al. Natural History, Tumor Growth Kinetics, and Renal Functional Outcomes of Sporadic Bilateral Multifocal Papillary Renal Cell Carcinoma: A 25-yr Prospective Cohort Study. Eur Urol Oncol. 2026. PMID: 42575757. doi:10.1016/j.euo.2026.07.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。